Fig. 7: In vivo anticancer activity of CMPBC.
From: Bioactive nanomotor enabling efficient intestinal barrier penetration for colorectal cancer therapy
a Schedule of the in vivo anticancer experiment. b Body weight change of mice during the treatment period (n = 5 mice). c In vivo bioluminescence images of mice at specified time points. d In vivo bioluminescence curves of mice during the treatment period (n = 5 mice). e Tumor weight in different groups following 3 weeks of treatment (n = 5 mice). f H&E staining and C-caspase (Cleaved-caspase) 3 staining analysis of tumor after treatment. g Incidence of tumor metastasis across different groups after treatment. h Survival analysis of tumor-bearing mice treated with saline, CP, and CMPBC + NIR over a 3-week period (n = 5 mice). Data are presented in the form of mean values ± SD. Significance was assessed using one-way ANOVA with Tukey’s post hoc test. Source data are provided as a Source Data file.
